{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T02:13:39Z","timestamp":1775787219559,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.autrev.2007.01.007","type":"journal-article","created":{"date-parts":[[2007,2,2]],"date-time":"2007-02-02T13:28:33Z","timestamp":1170422913000},"page":"341-346","source":"Crossref","is-referenced-by-count":32,"title":["Interpretative comments on autoantibody tests"],"prefix":"10.1016","volume":"6","author":[{"given":"Elio","family":"Tonutti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Visentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Bizzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2007.01.007_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cccn.2004.03.019","article-title":"What information on quality specifications should be communicated to clinicians, and how?","volume":"346","author":"Plebani","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.autrev.2007.01.007_bib2","unstructured":"ISO 15189: 2003. Medical laboratories. Particular requirements for quality and competence."},{"key":"10.1016\/j.autrev.2007.01.007_bib3","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1373\/clinchem.2003.024877","article-title":"Quality assessment of interpretative commenting in clinical chemistry","volume":"50","author":"Lim","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2007.01.007_bib4","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.007_bib5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"The American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthitis Rheum"},{"key":"10.1016\/j.autrev.2007.01.007_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.55.2.116","article-title":"Assessment of the European classification criteria for Sjogren syndrome in a series of clinically defined cases: results of a prospective multicentre study","volume":"55","author":"Vitali","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2007.01.007_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.autrev.2005.05.004","article-title":"Genes and goals: an approach to microarray analysis in autoimmunity","volume":"4","author":"Oertelt","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2007.01.007_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.0105-2896.2005.00251.x","article-title":"Protein arrays for studying blood cells and their secreted products","volume":"204","author":"Utz","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2007.01.007_bib9","first-page":"349","article-title":"Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice","volume":"22","author":"Bizzaro","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.007_bib10","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1309\/Y5VF-C3DM-L8XV-U053","article-title":"Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases","volume":"117","author":"Tozzoli","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2007.01.007_bib11","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.4049\/jimmunol.166.7.4780","article-title":"Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiple protein complexes involved in cell proliferation","volume":"166","author":"Takasaky","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2007.01.007_bib12","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1002\/art.10606","article-title":"Autoimmune responses to PCNA multiprotein complexes involved in cell proliferation are strongly associated with their structure and biological function in patients with systemic lupus erythematosus","volume":"46","author":"Kogure","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.007_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/art.20095","article-title":"Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us?","volume":"50","author":"Ganapathy","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.01.007_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1309\/WAEPADW0K4LPUHFN","article-title":"Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies","volume":"120","author":"Savige","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2007.01.007_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/08916930400022673","article-title":"Antineutrophil cytoplasmic antibodies (ANCA)","volume":"38","author":"Radice","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2007.01.007_bib16","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.1073\/pnas.0500132102","article-title":"The evolution of human anti-double-stranded DNA autoantibodies","volume":"102","author":"Wellmann","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2007.01.007_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","article-title":"International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA)","volume":"111","author":"Savige","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.autrev.2007.01.007_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"Atypical p-ANCA in IBD and hepatobilary disorders react with a 50\u00a0kD nuclear envelop protein of neutrophils and myeloid cell lines","volume":"199","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2007.01.007_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.autrev.2007.01.007_bib20","first-page":"255","article-title":"Autoantibodies to neutrophil cytoplasmic enzymes in Felty's syndrome","volume":"11","author":"Coremans","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.007_bib21","first-page":"525","article-title":"Discordance between anti-beta2-glycoprotein-I and anti-cardiolipin antibodies in patients with clinical criteria of antiphospholipid syndrome","volume":"23","author":"Micheloud","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2007.01.007_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1398-9995.1980.tb01768.x","article-title":"Granulocyte-specific antinuclear antibodies: possible significance for the pathogenesis, clinical features and diagnosis of rheumatoid arthritis","volume":"35","author":"Wiik","year":"1980","journal-title":"Allergy"},{"key":"10.1016\/j.autrev.2007.01.007_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1373\/clinchem.2003.028951","article-title":"Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them?","volume":"50","author":"Laposata","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2007.01.007_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2249.1999.01054.x","article-title":"Transglutaminase and coeliac disease: endomysial reactivity and small bowel expression","volume":"118","author":"Brusco","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2007.01.007_bib25","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/jcp.56.5.389","article-title":"The role of antitissue transglutaminase assay for the diagnosis and monitoring of celiac disease: a French\u2013Italian multicentre study","volume":"56","author":"Tonutti","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2007.01.007_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/S0022-3476(03)00282-8","article-title":"A prospective study of the incidence of childhood celiac disease","volume":"143","author":"Hoffenberg","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.autrev.2007.01.007_bib27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jcp.2004.016261","article-title":"What happens to patients with positive tissue transglutaminase and endomysium antibody results in general practice?","volume":"57","author":"Sinclair","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2007.01.007_bib28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0168-8278(02)00322-7","article-title":"Anti-mitochondrial antibodies in primary biliary cirrhosis","volume":"37","author":"Neuberger","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.autrev.2007.01.007_bib29","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1023\/B:DDAS.0000037811.48575.da","article-title":"Survival of anti-mitochondrial antibody-positive and-negative primary biliary cirrhosis patients on urodeoxycholic acid treatment","volume":"49","author":"Koulentaki","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2007.01.007_bib30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1365-2249.1999.00909.x","article-title":"Anti-tissue transglutaminase, anti-endomysium and anti-R1-reticulin autoantibodies; the antibody trinity of coeliac disease","volume":"116","author":"Lock","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2007.01.007_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00365529609031628","article-title":"Value of serologic markers for clinical diagnosis and population studies of coeliac disease","volume":"3","author":"Ascher","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.autrev.2007.01.007_bib32","first-page":"167","article-title":"Serologic markers in inflammatory bowel disease: state of the art","volume":"4","author":"Sandborn","year":"2004","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.autrev.2007.01.007_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1023\/A:1019926121972","article-title":"Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease","volume":"22","author":"Damoiseaux","year":"2002","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.autrev.2007.01.007_bib34","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3748\/wjg.v9.i10.2308","article-title":"Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease","volume":"9","author":"Berta","year":"2003","journal-title":"World J Gastroenterol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T10:25:14Z","timestamp":1547029514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997207000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1568997207000183"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2007.01.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}